Effects of Combined Blue and Red Home-Based Light Therapy on Sleep in Adults With Self-Reported Sleep Difficulties
IMPACT OF LIGHT THERAPY ON SLEEP AND PERFORMANCE
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this intervention is to learn if a combination of morning blue light and evening red light therapy can improve sleep quality in adults with subclinical sleep complaints (non-diagnosed difficulty initiating or maintaining sleep). The main questions it aims to answer are: Does combined morning blue light and evening red light therapy reduce sleep onset latency (the time it takes to fall asleep) and improve sleep efficiency? Does this light therapy intervention improve subjective alertness upon awakening? Researchers will compare each participant's objective and subjective sleep data during a 7-day baseline (habitual routine) with their data during a 7-day light therapy intervention to assess whether light therapy improves sleep and daytime alertness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 7, 2025
CompletedFirst Submitted
Initial submission to the registry
February 17, 2026
CompletedFirst Posted
Study publicly available on registry
March 11, 2026
CompletedMarch 12, 2026
March 1, 2026
12 months
February 17, 2026
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sleep Onset Latency
Sleep Onset Latency (SOL) is the amount of time (measured in minutes) it takes a participant to fall asleep after getting into bed. This will be measured objectively using a 24-hour wrist-worn actigraphy device. The study will compare the average SOL during the 7-day habitual baseline period (Control) to the average SOL during the 7-day light therapy intervention period (Treatment) to assess the efficacy of the dual-spectrum light exposure.
Average of 7 days during the Control phase (Days 1-7) and average of 7 days during the Treatment phase (Days 8-14).
Secondary Outcomes (2)
Total Sleep Time
Average of 7 days during the Control phase (Days 1-7) and average of 7 days during the Treatment phase (Days 8-14).
Subjective Morning Alertness
Daily upon awakening for 15 days.
Study Arms (1)
LED Light Therapy
EXPERIMENTALParticipants in this single-arm study follow a within-subject consecutive design. All participants complete a 7-day baseline period (Control) following their habitual routine, followed immediately by a 7-day intervention period (Treatment). The intervention consists of: Morning Exposure: 2 hours of short-wavelength blue light exposure immediately upon waking. Evening Exposure: 2 hours of long-wavelength red light exposure during the 2 hours prior to the participant's anticipated bedtime. The primary goal of this arm is to assess the impact of this dual-light protocol on objective sleep onset latency and subjective morning alertness compared to the participant's own baseline data.
Interventions
Unlike studies that use only bright white light or single-wavelength blue light, this intervention combines morning short-wavelength (blue) light with evening long-wavelength (red) light. This study specifically targets individuals with "subclinical" sleep complaints-those with a Pittsburgh Sleep Quality Index (PSQI) score \>1-rather than patients already diagnosed with clinical insomnia or Circadian Rhythm Sleep Disorders. The protocol requires a precise 4-hour daily total exposure (2 hours in the morning and 2 hours in the evening), which is more intensive than many standard 30-minute light box protocols. This is an at-home intervention where participants use portable lamp mounting options to integrate 4 hours of therapy into their regular daily activities, rather than receiving treatment in a controlled laboratory setting.
Eligibility Criteria
You may qualify if:
- Adults age 18 and older
- Subclinical complaints of disrupted sleep or poor sleep quality
- a score of 3 or greater on the Pittsburgh Sleep Quality Index (PSQI)
You may not qualify if:
- Younger than 18 years of age,
- Complaints of disrupted or poor sleep with a PSQI score of less than 2
- Previously diagnosed clinical sleep disorder, such as insomnia or Circadian Rhythm Sleep Disorder (CRSD)
- Employment in evening, night, or rotating shifts
- Engagement in irregular sleep patterns that are not aligned with the biological night
- Inability to comply with the study protocol and at-home study requirements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Colorado State University
Fort Collins, Colorado, 80523, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Josiane L Broussard, PhD
Colorado State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 17, 2026
First Posted
March 11, 2026
Study Start
July 9, 2024
Primary Completion
July 7, 2025
Study Completion
July 7, 2025
Last Updated
March 12, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share